Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assaySavino Sciascia, Dario Roccatello, Simone Baldovino et al.|Clinical and Molecular Allergy|2016Cited by 48
Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohortDario Roccatello, Elisa Menegatti, Savino Sciascia et al.|BMJ Open|2017Cited by 38
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patientsSavino Sciascia, Dario Roccatello, Massimo Radin et al.|Lara D. Veeken|2019Cited by 37
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot studySavino Sciascia, Simone Baldovino, Dario Roccatello et al.|Inflammation Research|2012Cited by 33
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et alMassimo Radin, Simone Baldovino, Savino Sciascia et al.|Arthritis & Rheumatology|2020Cited by 25